PICCOLO trial met its primary endpoint of objective response rate (ORR)
Merck has opened its newly expanded Life Science distribution center in Schnelldorf, Germany
The special Tele MANAS cell to serve as a dedicated mental health assistance helpline for all Armed Forces beneficiaries across country
This acquisition complements AstraZeneca’s leading oncology portfolio with the addition of the Fusion pipeline of RCs
Third Phase 3 trial in third type of lymphoma to show improvement in overall survival with an ADCETRIS-containing regimen
The HD21 study adds to the body of evidence supporting ADCETRIS as a backbone agent in the treatment of specific lymphomas
Facility in The Woodlands, Texas to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025
Sacubitril and Valsartan Tablets are indicated to reduce the risk of cardiovascular death
Acceptance based on results demonstrated a statistically significant improvement in overall survival versus chemotherapy alone in these patients
The new facility will accelerate the biotech and pharmaceutical industry's development by manufacturing vaccines, cell and gene therapies, and protein-based therapies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
